Porphyran
APC-1751
Porphyran
Cat. No.
APC-1751
CAS No.
11016-36-7
MF
C26H44O27S2-2
MW
852.7
Porphyran is a sulfated galactan that can be used for the structural characterization of marine polysaccharides, glycan chain analysis, and the development of natural polysaccharide-based materials.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
CAS No.
11016-36-7
MF
C26H44O27S2-2
MW
852.7
Specification
98%
Research Area
Antioxidant, anti-inflammatory, immunomodulatory, anticancer, antidiabetic, antihyperlipidemic
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Porphyran is a sulfated galactan that can be used for the structural characterization of marine polysaccharides, glycan chain analysis, and the development of natural polysaccharide-based materials. Plant Source: Genus Porphyra Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat.
References
[1]. Pradhan B, Rout L, Ki JS. Immunomodulatory and anti-inflammatory and anticancer activities of porphyran, a sulfated galactan. Carbohydr Polym. 2023 Feb 1;301(Pt A):120326. [2]. Qiu Y, Jiang H, Fu L, Ci F, Mao X. Porphyran and oligo-porphyran originating from red algae Porphyra: Preparation, biological activities, and potential applications. Food Chem. 2021 Jul 1;349:129209.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
